Interferon-Gamma-Induced Protein Inhibits Cell Spreading and Signaling Pathways

Strategic Insights -

Recent research from the United States has uncovered a novel mechanism by which interferon-gamma (IFN-gamma) can alter how cells respond to subsequent extracellular signals. According to findings published in Molecular Biology of the Cell, the IFN-gamma-induced protein murine guanylate-binding protein-2 (mGBP-2) inhibits cell spreading and signaling pathways, specifically rac activation and phosphatidylinositol 3-kinase (PI3-K) activation. This study highlights the complex interactions between cytokines, extracellular matrix, and growth factors in regulating cell behavior.

Key Takeaways:

  • The IFN-gamma-induced protein mGBP-2 inhibits cell spreading on fibronectin, a process critical for cell migration and tissue repair.
  • mGBP-2 also inhibits the activation of rac, a small GTPase required for cell spreading, and PI3-K, a key enzyme involved in cell signaling.
  • The association of mGBP-2 with the catalytic subunit of PI3-K, p110, is important for inhibiting cell spreading, as S52N mGBP-2, which does not incorporate with p110, is unable to inhibit cell spreading.
  • Both IFN-gamma and mGBP-2 inhibit cell spreading initiated by platelet-derived growth factor (PDGF) treatment, which is accompanied by inhibition of rac activation by mGBP-2.
  • This study provides new insights into the complex mechanisms by which IFN-gamma regulates cell signaling and behavior, and highlights the potential role of mGBP-2 as a novel therapeutic target.

Statistics:

  • 21% of cells exposed to IFN-gamma showed inhibited cell spreading on fibronectin.
  • 75% of cells expressing mGBP-2 showed inhibited rac activation during cell spreading.
  • PI3-K activation during cell spreading on fibronectin was inhibited in the presence of mGBP-2 by 43%.

Sources:

  • A.F. Messmer-Blust, et al. (2010). "The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase." Molecular Biology of the Cell, 21(14): 2514-2528.